1) Haematologica 2010; 95[suppl.2]:11, abs. 0026
LOSS OF RKIP IN ACUTE MYELOID LEUKEMIA WITH A MONOCYTIC PHENOTYPE |
2) Haematologica 2010; 95[suppl.2]:11, abs. 0027
DIFFERENTIAL RESPONSES TO CXCR4 ANTAGONISM IDENTIFY TWO BIOLOGICAL DISTINCT SUBTYPES OF ACUTE MYELOID LEUKEMIA IN TRANSPLANTED NOD/SCID MICE |
3) Haematologica 2010; 95[suppl.2]:12, abs. 0028
HIGH BRE EXPRESSION IS ASSOCIATED WITH T(9;11)(P21;Q23) AND A FAVORABLE OUTCOME IN PEDIATRIC ACUTE MYELOID LEUKEMIA |
4) Haematologica 2010; 95[suppl.2]:12, abs. 0029
DIFFERENTIAL ROLE OF MYELOID TRANSCRIPTION FACTORS, C/EBPα AND PU.1 IN LEUKEMOGENESIS BY MLL-FUSION ONCOGENES |
5) Haematologica 2010; 95[suppl.2]:12, abs. 0030
TET2 MUTATIONS OCCUR IN OVER 20% OF ADULTS WITH DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA, AND THEIR PREVALENCE INCREASES WITH AGE: A CANCER AND LEUKEMIA GROUP B STUDY |
6) Haematologica 2010; 95[suppl.2]:13, abs. 0031
BONE MARROW FAILURE IN ACUTE MYELOID LEUKEMIA IS INDUCED BY A BLOCK IN DIFFERENTIATION OF NORMAL HEMATOPOIETIC STEM CELLS |
7) Haematologica 2010; 95[suppl.2]:13, abs. 0032
INFLUENCE ON OUTCOME OF THE NPM1/FLT3-ITD MOLECULAR STATUS FOR AML PATIENTS IN FIRST COMPLETE REMISSION TREATED BY AUTO- OR ALLO-HSCT: RESULTS OF THE PROSPECTIVE GOELAMS LAM-2001 TRIAL |
8) Haematologica 2010; 95[suppl.2]:14, abs. 0033
INDUCTION OF A CD8+ T CELL RESPONSE TO THE MAGE CANCER TESTIS ANTIGEN BY COMBINED TREATMENT WITH AZACITIDINE AND SODIUM VALPROATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASIA |
9) Haematologica 2010; 95[suppl.2]:14, abs. 0034
DISTINCT CLINICAL AND BIOLOGICAL CHARACTERISTICS OF ADULT PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA WITH ADDITIONAL SEX COMB-LIKE 1 (ASXL1) MUTATION |
10) Haematologica 2010; 95[suppl.2]:15, abs. 0035
SUPPRESSOR OF CYTOKINE SIGNALING (SOCS1) COOPERATES WITH FLT3-ITD IN THE DEVELOPMENT OF MYELOPROLIFERATIVE DISEASE BY PROMOTING THE ESCAPE FROM EXTERNAL CYTOKINE CONTROL |
11) Haematologica 2010; 95[suppl.2]:15, abs. 0036
THE NON-HOMEODOMAIN SPLICE VARIANT HOXA9T CAUSES LEUKEMIA ON ITS OWN AND COLLABO-RATES WITH HOXA9 TO INDUCE SHORT - LATENCY AML IN MICE |
12) Haematologica 2010; 95[suppl.2]:15, abs. 0037
HIGH-RESOLUTION MOLECULAR ALLELOKARYOTYPING IDENTIFIES NOVEL UNIPARENTAL DISOMY AND FOCAL COPY NUMBER
ALTERATIONS IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) |
13) Haematologica 2010; 95[suppl.2]:16, abs. 0038
CLINICAL IMPLICATIONS OF A SPECIFIC METHYLATION PROFILE IN ACUTE MYELOID LEUKEMIA |
14) Haematologica 2010; 95[suppl.2]:16, abs. 0039
IL-12 DEBULKS PEDIATRIC ACUTE MYELOID LEUKEMIA CELLS BY ACTING ON TUMOR INITIATING CELLS IN VIVO |
15) Haematologica 2010; 95[suppl.2]:16, abs. 0040
THE VENT-LIKE HOMEOBOX GENE VENTX IS A NOVEL HUMAN HEMATOPOIETIC FACTOR, WHICH PROMOTES MYELOID DEVELOPMENT AND IS HIGHLY EXPRESSED IN ACUTE MYELOID LEUKEMIA |
16) Haematologica 2010; 95[suppl.2]:17, abs. 0041
BIOLOGICAL CHARACTERIZATION OF AML AT THE SINGLE CELL LEVEL BASED ON RESPONSE TO DNA DAMAGING AGENTS |
17) Haematologica 2010; 95[suppl.2]:17, abs. 0042
A HIGH AMOUNT OF CD34+ CD38LOW/NEG CD123+ CELLS HAS AN ADVERSE IMPACT ON DISEASE FREE AND OVERALL SURVIVAL IN AML PATIENTS TREATED BY INTENSIVE CHEMOTHERAPY |
18) Haematologica 2010; 95[suppl.2]:18, abs. 0043
THE MOLECULAR PATHWAYS AFFECTED BY THE AML ASSOCIATED ONCOFUSION PROTEINS AML1-ETO AND PML-RAR |
19) Haematologica 2010; 95[suppl.2]:18, abs. 0044
TARGETED INHIBITION OF MTOR BY AZD8055 BLOCKS PROTEIN TRANSLATION AND HAS ANTI-LEUKEMIC ACTIVITY IN ACUTE MYELOID LEUKEMIA |
20) Haematologica 2010; 95[suppl.2]:18, abs. 0045
TARGETING HEMATOPOIETIC STEM CELLS EXPANSION IN C/EBPALPHA MUTANT AML |
21) Haematologica 2010; 95[suppl.2]:19, abs. 0046
TARGETING IRON HOMEOSTASIS INDUCES CELLULAR DIFFERENTIATION AND SYNERGIZES WITH DIFFERENTIATING AGENTS IN ACUTE MYELOID LEUKEMIA |
22) Haematologica 2010; 95[suppl.2]:19, abs. 0047
MONITORING OF ABERRANTLY METHYLATED GENES IN AML PATIENTS |
23) Haematologica 2010; 95[suppl.2]:19, abs. 0048
SNP ARRAYS ANALYSIS REVEALS FREQUENT AND RECURRENT ACQUIRED GENOMIC ALTERATIONS IN AML COPY NUMBER VARIATIONS OR UNIPARENTAL DISOMY (A STUDY OF THE ALFA GROUP) |
24) Haematologica 2010; 95[suppl.2]:20, abs. 0049
ACCUMULATION OF 2-HYDROXYGLUTARATE (2-HG) IN NORMAL KARYOTYPE AML PATIENTS WITH IDH1 MUTATION |
25) Haematologica 2010; 95[suppl.2]:20, abs. 0050
THE FOUR AND A HALF LIM DOMAIN PROTEIN 2 (FHL2) INTERACTS WITH CALM AND IS HIGHLY EXPRESSED IN ACUTE ERYTHROLEUKEMIA |